- Home
- EVOK vs LCFY Comparison
EVOK vs LCFY Comparison
Compare EVOK & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- LCFY
- Stock Information
- Founded
- EVOK 2007
- LCFY 2009
- Country
- EVOK United States
- LCFY Australia
- Employees
- EVOK N/A
- LCFY N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- LCFY
- Sector
- EVOK Health Care
- LCFY
- Exchange
- EVOK Nasdaq
- LCFY Nasdaq
- Market Cap
- EVOK 7.1M
- LCFY 9.9M
- IPO Year
- EVOK 2013
- LCFY 2022
- Fundamental
- Price
- EVOK $3.61
- LCFY $6.00
- Analyst Decision
- EVOK
- LCFY
- Analyst Count
- EVOK 0
- LCFY 0
- Target Price
- EVOK N/A
- LCFY N/A
- AVG Volume (30 Days)
- EVOK 11.4K
- LCFY 13.8K
- Earning Date
- EVOK 03-13-2025
- LCFY 04-30-2025
- Dividend Yield
- EVOK N/A
- LCFY N/A
- EPS Growth
- EVOK N/A
- LCFY N/A
- EPS
- EVOK N/A
- LCFY N/A
- Revenue
- EVOK $8,617,036.00
- LCFY $2,668,385.00
- Revenue This Year
- EVOK $97.35
- LCFY N/A
- Revenue Next Year
- EVOK $99.52
- LCFY N/A
- P/E Ratio
- EVOK N/A
- LCFY N/A
- Revenue Growth
- EVOK 100.35
- LCFY N/A
- 52 Week Low
- EVOK $3.44
- LCFY $2.20
- 52 Week High
- EVOK $12.32
- LCFY $11.23
- Technical
- Relative Strength Index (RSI)
- EVOK 32.70
- LCFY 38.25
- Support Level
- EVOK $3.68
- LCFY $5.08
- Resistance Level
- EVOK $4.22
- LCFY $8.80
- Average True Range (ATR)
- EVOK 0.44
- LCFY 0.52
- MACD
- EVOK -0.13
- LCFY -0.11
- Stochastic Oscillator
- EVOK 13.98
- LCFY 25.89
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.